aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Sinopia Biosciences, based in San Diego, is revolutionizing drug discovery through data-driven, high-throughput multi-omics and machine learning. The company aims to address the complexities of disease etiology and pathogenesis by moving beyond traditional target-based approaches to more productive phenotypic screening methods. Sinopia's core mission is to enhance the discovery of first-in-class medicines by leveraging advanced biological insights and computational techniques.
Notable affiliated individuals and investors include experts in biotechnology and computational biology, although specific names are not provided. Key achievements include the development of innovative methodologies that have significantly improved the productivity of drug discovery processes. Sinopia Biosciences' overall impact lies in its potential to transform how diseases are studied and treated, offering new hope for complex conditions that have eluded traditional research methods.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Drug Discovery
Technology
AI, Machine Learning
Tags
Biotech, Data
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Sinopia Biosciences founded?
Sinopia Biosciences was founded in 2011.
Where is Sinopia Biosciences's headquarters located?
Sinopia Biosciences's headquarters is located in San Diego, CA, US.
When was Sinopia Biosciences's last funding round?
Sinopia Biosciences's most recent funding round was for $318k (USD) in September 2022.
How many employees does Sinopia Biosciences have?
Sinopia Biosciences has 8 employees as of Feb 4, 2024.
How much has Sinopia Biosciences raised to-date?
As of July 05, 2023, Sinopia Biosciences has raised a total of $14.1M (USD) since Sep 20, 2022.
Add Comparison
Total Raised to Date
$14.1M
USD
Last Update Sep 20, 2022
Last Deal Details
$318k
USD
Sep 20, 2022
Grant
Total Employees Over Time
8
As of Feb 2024
Sinopia Biosciences Address
3210 Null Merryfield Row
San Diego,
California
92121
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts